PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SHGTX vs. FPHAX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Performance

SHGTX vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Columbia Seligman Global Technology Fund (SHGTX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
9.57%
-7.77%
SHGTX
FPHAX

Returns By Period

In the year-to-date period, SHGTX achieves a 22.96% return, which is significantly higher than FPHAX's 11.82% return. Over the past 10 years, SHGTX has outperformed FPHAX with an annualized return of 10.08%, while FPHAX has yielded a comparatively lower 3.15% annualized return.


SHGTX

YTD

22.96%

1M

3.52%

6M

8.80%

1Y

25.20%

5Y (annualized)

11.84%

10Y (annualized)

10.08%

FPHAX

YTD

11.82%

1M

-10.04%

6M

-8.25%

1Y

16.74%

5Y (annualized)

4.18%

10Y (annualized)

3.15%

Key characteristics


SHGTXFPHAX
Sharpe Ratio1.161.00
Sortino Ratio1.621.46
Omega Ratio1.221.18
Calmar Ratio1.090.86
Martin Ratio5.863.44
Ulcer Index4.12%4.62%
Daily Std Dev20.77%16.00%
Max Drawdown-82.03%-37.34%
Current Drawdown-0.83%-16.56%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SHGTX vs. FPHAX - Expense Ratio Comparison

SHGTX has a 1.29% expense ratio, which is higher than FPHAX's 0.75% expense ratio.


SHGTX
Columbia Seligman Global Technology Fund
Expense ratio chart for SHGTX: current value at 1.29% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.29%
Expense ratio chart for FPHAX: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%

Correlation

-0.50.00.51.00.6

The correlation between SHGTX and FPHAX is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Risk-Adjusted Performance

SHGTX vs. FPHAX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Columbia Seligman Global Technology Fund (SHGTX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SHGTX, currently valued at 1.16, compared to the broader market-1.000.001.002.003.004.005.001.161.00
The chart of Sortino ratio for SHGTX, currently valued at 1.62, compared to the broader market0.005.0010.001.621.46
The chart of Omega ratio for SHGTX, currently valued at 1.22, compared to the broader market1.002.003.004.001.221.18
The chart of Calmar ratio for SHGTX, currently valued at 1.09, compared to the broader market0.005.0010.0015.0020.0025.001.090.86
The chart of Martin ratio for SHGTX, currently valued at 5.86, compared to the broader market0.0020.0040.0060.0080.00100.005.863.44
SHGTX
FPHAX

The current SHGTX Sharpe Ratio is 1.16, which is comparable to the FPHAX Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of SHGTX and FPHAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
1.16
1.00
SHGTX
FPHAX

Dividends

SHGTX vs. FPHAX - Dividend Comparison

SHGTX has not paid dividends to shareholders, while FPHAX's dividend yield for the trailing twelve months is around 0.76%.


TTM20232022202120202019201820172016201520142013
SHGTX
Columbia Seligman Global Technology Fund
0.00%0.00%0.00%0.00%0.27%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FPHAX
Fidelity Select Pharmaceuticals Portfolio
0.76%0.63%1.33%1.17%1.31%1.31%1.44%1.33%1.07%5.59%5.81%11.12%

Drawdowns

SHGTX vs. FPHAX - Drawdown Comparison

The maximum SHGTX drawdown since its inception was -82.03%, which is greater than FPHAX's maximum drawdown of -37.34%. Use the drawdown chart below to compare losses from any high point for SHGTX and FPHAX. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-0.83%
-16.56%
SHGTX
FPHAX

Volatility

SHGTX vs. FPHAX - Volatility Comparison

The current volatility for Columbia Seligman Global Technology Fund (SHGTX) is 5.36%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 6.27%. This indicates that SHGTX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
5.36%
6.27%
SHGTX
FPHAX